Improving The Oncology Patient Experience In Clinical Trials

Every patient’s clinical trial journey is distinctive. When navigating cancer, patients can endure major physical pain and discomfort as well as the emotional distress that accompanies their diagnosis. Clinical trials offer oncology patients access to therapies that would otherwise be unaffordable, alongside the potential to feel better and live longer. If a patient is in the late stages of their diagnosis, participating in a clinical trial affords hope during a deeply difficult experience. Furthermore, trials offer patients the opportunity to contribute to a therapy that could one day help others in a similar situation.

However, traditional clinical trials can add a significant burden onto patients in terms of travel time, discomfort, and care team communication. Decentralized clinical trials (DCTs), which use remote or hybrid components, are one solution to help make oncology clinical trials more accessible and easier for patients to benefit from. Download the full article to read about the obstacles of one patient’s clinical trial journey and how DCT components could have improved it.